# Perindopril vs Ramipril for Persistence in MAU Reduction Study

> **NCT02729441** · PHASE3 · COMPLETED · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 23 (actual)

## Conditions studied

- Diabetes
- Microalbuminuria

## Interventions

- **DRUG:** ramipril
- **DRUG:** perindopril

## Key facts

- **NCT ID:** NCT02729441
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2012-08
- **Final completion:** 2012-12
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2016-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02729441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02729441, "Perindopril vs Ramipril for Persistence in MAU Reduction Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02729441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*